News summary
[Yahong Medicinefortunebingo: The listing application for hexyl parvalinate hydrochloride ointment photodynamic therapy system was accepted] Securities Times e Company News, Yahong Pharmaceutical (688176) announced on the evening of May 12 and received approval and issuance from the State Food and Drug Administrationfortunebingo"Acceptance Notice", the company's product APL-1702 (fortunebingo.fortunebingo..
Newsletter text
[Yahong Pharmaceutical: The application for marketing of hexyl parvalinate hydrochloride ointment photodynamic therapy system was accepted] Securities Times e Company News, Yahong Pharmaceutical (688176) announced on the evening of May 12 that it received the "Acceptance Notice" approved and issued by the State Food and Drug Administration ", the company's product APL-1702 (Common name: Hexyl Formalate Hydrochloride Ointment Photodynamic Therapy System) The marketing application for the treatment of patients aged 18 and above with histologically confirmed high-grade squamous intraepithelial lesions (HSIL) in the cervix who have been excluded from carcinoma in situ has been accepted.
